Geddes DM - Search Results

1

Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects.

Nichol GM, Alton EW, Nix A, Geddes DM, Chung KF, Barnes PJ. Nichol GM, et al. Among authors: geddes dm. Am Rev Respir Dis. 1990 Sep;142(3):576-80. doi: 10.1164/ajrccm/142.3.576. Am Rev Respir Dis. 1990. PMID: 2202247 Clinical Trial.

2

The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis.

Davies MG, Geddes DM, Alton EW. Davies MG, et al. Among authors: geddes dm. Am J Respir Crit Care Med. 2005 Apr 1;171(7):760-3. doi: 10.1164/rccm.200310-1423OC. Epub 2004 Dec 23. Am J Respir Crit Care Med. 2005. PMID: 15618459

3

Nasal potential difference: a clinical diagnostic test for cystic fibrosis.

Alton EW, Currie D, Logan-Sinclair R, Warner JO, Hodson ME, Geddes DM. Alton EW, et al. Among authors: geddes dm. Eur Respir J. 1990 Sep;3(8):922-6. Eur Respir J. 1990. PMID: 2292287

4

Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.

Middleton PG, Geddes DM, Alton EW. Middleton PG, et al. Among authors: geddes dm. Thorax. 1993 Aug;48(8):812-6. doi: 10.1136/thx.48.8.812. Thorax. 1993. PMID: 8211871 Free PMC article. Clinical Trial.

5

Trimethoprim and tetracycline inhibit airway epithelial sodium absorption.

Middleton PG, Geddes DM, Alton EW. Middleton PG, et al. Among authors: geddes dm. Am J Respir Crit Care Med. 1996 Jul;154(1):18-23. doi: 10.1164/ajrccm.154.1.8680677. Am J Respir Crit Care Med. 1996. PMID: 8680677

6

Potential difference measurements in the lower airway of children with and without cystic fibrosis.

Davies JC, Davies M, McShane D, Smith S, Chadwick S, Jaffe A, Farley R, Collins L, Bush A, Scallon M, Pepper J, Geddes DM, Alton EW. Davies JC, et al. Among authors: geddes dm. Am J Respir Crit Care Med. 2005 May 1;171(9):1015-9. doi: 10.1164/rccm.200408-1116OC. Epub 2005 Jan 7. Am J Respir Crit Care Med. 2005. PMID: 15640364

7

Exploring the mechanisms of macrolides in cystic fibrosis.

Equi AC, Davies JC, Painter H, Hyde S, Bush A, Geddes DM, Alton EW. Equi AC, et al. Among authors: geddes dm. Respir Med. 2006 Apr;100(4):687-97. doi: 10.1016/j.rmed.2005.07.016. Epub 2005 Sep 26. Respir Med. 2006. PMID: 16185859 Free article.

8

The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.

Smith SN, Middleton PG, Chadwick S, Jaffe A, Bush KA, Rolleston S, Farley R, Delaney SJ, Wainwright B, Geddes DM, Alton EW. Smith SN, et al. Among authors: geddes dm. Am J Respir Cell Mol Biol. 1999 Jan;20(1):129-34. doi: 10.1165/ajrcmb.20.1.3278. Am J Respir Cell Mol Biol. 1999. PMID: 9870926

9

Taking stock of gene therapy for cystic fibrosis.

Stern M, Geddes DM, Alton EW. Stern M, et al. Among authors: geddes dm. Respir Res. 2000;1(2):78-81. doi: 10.1186/rr16. Epub 2000 Sep 15. Respir Res. 2000. PMID: 11667969 Free PMC article. Review.

10

Airway surface pH in subjects with cystic fibrosis.

McShane D, Davies JC, Davies MG, Bush A, Geddes DM, Alton EW. McShane D, et al. Among authors: geddes dm. Eur Respir J. 2003 Jan;21(1):37-42. doi: 10.1183/09031936.03.00027603. Eur Respir J. 2003. PMID: 12570106 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page